Lumos Diagnostics Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Lumos Diagnostics Holdings's earnings have been declining at an average annual rate of -7.3%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 0.9% per year.
Anahtar bilgiler
-7.3%
Kazanç büyüme oranı
39.2%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 5.8% |
Gelir büyüme oranı | 0.9% |
Özkaynak getirisi | -120.9% |
Net Marj | -77.2% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Lumos Diagnostics Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 11 | -9 | 12 | 0 |
31 Mar 24 | 10 | -9 | 11 | 0 |
31 Dec 23 | 8 | -9 | 11 | 0 |
30 Sep 23 | 9 | -9 | 11 | 0 |
30 Jun 23 | 11 | -9 | 12 | 0 |
31 Mar 23 | 11 | -25 | 15 | 1 |
31 Dec 22 | 12 | -41 | 19 | 1 |
30 Sep 22 | 12 | -43 | 21 | 1 |
30 Jun 22 | 12 | -46 | 24 | 1 |
31 Mar 22 | 14 | -34 | 24 | 1 |
31 Dec 21 | 16 | -23 | 24 | 1 |
30 Sep 21 | 17 | -19 | 21 | 1 |
30 Jun 21 | 19 | -15 | 18 | 1 |
31 Mar 21 | 16 | -12 | 16 | 2 |
31 Dec 20 | 12 | -9 | 15 | 2 |
30 Sep 20 | 9 | -9 | 13 | 2 |
30 Jun 20 | 6 | -9 | 11 | 2 |
30 Jun 19 | 4 | -5 | 4 | 1 |
30 Jun 18 | 2 | -1 | 2 | 0 |
Kaliteli Kazançlar: LDX is currently unprofitable.
Büyüyen Kar Marjı: LDX is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: LDX is unprofitable, and losses have increased over the past 5 years at a rate of 7.3% per year.
Büyüme Hızlandırma: Unable to compare LDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: LDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Özkaynak Getirisi
Yüksek ROE: LDX has a negative Return on Equity (-120.86%), as it is currently unprofitable.